CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

Yoichi Matsuo, Massimo Raimondo, Timothy A. Woodward, Michael B. Wallace, Kanwar R. Gill, Zhimin Tong, Marie D. Burdick, Zhijian Yang, Robert M. Strieter, Robert M. Hoffman, Sushovan Guha

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Angiogenesis is essential for tumor growth and metastasis. Although ELR+-CXC-chemokines and their corresponding receptor, CXC-receptor 2 (CXCR2), are known mediators of angiogenesis, little is known about their role in pancreatic cancer (PaCa). The aim of our study was to determine the role of ELR+-CXCchemokine/ CXCR2 biological axis in promoting PaCa angiogenesis. We prospectively collected secretin-stimulated exocrine pancreatic secretions (SSEPS) from normal individuals (NP) and PaCa patients. We showed that summed concentrations of ELR+-CXC-chemokines in SSEPS from PaCa patients were significantly higher than in those from NP (p = 0.002). We measured ELR+-CXC-chemokine levels in supernatants from multiple PaCa cell lines and confirmed that BxPC-3, Colo-357 and Panc-28 had significantly higher expression compared with an immortalized human pancreatic ductal epithelial (HPDE) cell line. After confirming lack of autocrine effects of ELR1-CXC-chemokines on PaCa cells (due to absence of CXCR2 expression), we investigated paracrine effects of these chemokines on human umbilical vein endothelial cells (HUVEC). Both recombinant ELR+-CXC-chemokines and co-culturing with BxPC-3 significantly enhanced proliferation, invasion, and tube formation of HUVEC (p < 0.05). These biological effects were significantly inhibited by treatment with a neutralizing antibody against CXCR2 (anti-CXCR2 Ab) (p < 0.05). Finally, anti-CXCR2 Ab significantly reduced tumor volume (p < 0.05), Ki-67 proliferation index (p = 0.043) and Factor VIII+ microvessel density (p = 0.004) in an orthotopic nude mouse PaCa model. Our results show that ELR+-CXC-chemokines promote PaCa tumor-associated angiogenesis through CXCR2, suggesting that CXCR2 is an anti-angiogenic target in PaCa.

Original languageEnglish (US)
Pages (from-to)1027-1037
Number of pages11
JournalInternational Journal of Cancer
Volume125
Issue number5
DOIs
StatePublished - Sep 1 2009

Fingerprint

Interleukin-8B Receptors
Pancreatic Neoplasms
CXC Chemokines
Secretin
Human Umbilical Vein Endothelial Cells
In Vitro Techniques
Cell Line
Factor VIII
Microvessels
Neutralizing Antibodies
Tumor Burden
Chemokines
Nude Mice
Neoplasms
Epithelial Cells

Keywords

  • Angiogenesis
  • CXCR2
  • ELR-CXC-chemokines
  • Pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. / Matsuo, Yoichi; Raimondo, Massimo; Woodward, Timothy A.; Wallace, Michael B.; Gill, Kanwar R.; Tong, Zhimin; Burdick, Marie D.; Yang, Zhijian; Strieter, Robert M.; Hoffman, Robert M.; Guha, Sushovan.

In: International Journal of Cancer, Vol. 125, No. 5, 01.09.2009, p. 1027-1037.

Research output: Contribution to journalArticle

Matsuo, Y, Raimondo, M, Woodward, TA, Wallace, MB, Gill, KR, Tong, Z, Burdick, MD, Yang, Z, Strieter, RM, Hoffman, RM & Guha, S 2009, 'CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer', International Journal of Cancer, vol. 125, no. 5, pp. 1027-1037. https://doi.org/10.1002/ijc.24383
Matsuo, Yoichi ; Raimondo, Massimo ; Woodward, Timothy A. ; Wallace, Michael B. ; Gill, Kanwar R. ; Tong, Zhimin ; Burdick, Marie D. ; Yang, Zhijian ; Strieter, Robert M. ; Hoffman, Robert M. ; Guha, Sushovan. / CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. In: International Journal of Cancer. 2009 ; Vol. 125, No. 5. pp. 1027-1037.
@article{899d61d06252478ebb5332cc3b91ef11,
title = "CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer",
abstract = "Angiogenesis is essential for tumor growth and metastasis. Although ELR+-CXC-chemokines and their corresponding receptor, CXC-receptor 2 (CXCR2), are known mediators of angiogenesis, little is known about their role in pancreatic cancer (PaCa). The aim of our study was to determine the role of ELR+-CXCchemokine/ CXCR2 biological axis in promoting PaCa angiogenesis. We prospectively collected secretin-stimulated exocrine pancreatic secretions (SSEPS) from normal individuals (NP) and PaCa patients. We showed that summed concentrations of ELR+-CXC-chemokines in SSEPS from PaCa patients were significantly higher than in those from NP (p = 0.002). We measured ELR+-CXC-chemokine levels in supernatants from multiple PaCa cell lines and confirmed that BxPC-3, Colo-357 and Panc-28 had significantly higher expression compared with an immortalized human pancreatic ductal epithelial (HPDE) cell line. After confirming lack of autocrine effects of ELR1-CXC-chemokines on PaCa cells (due to absence of CXCR2 expression), we investigated paracrine effects of these chemokines on human umbilical vein endothelial cells (HUVEC). Both recombinant ELR+-CXC-chemokines and co-culturing with BxPC-3 significantly enhanced proliferation, invasion, and tube formation of HUVEC (p < 0.05). These biological effects were significantly inhibited by treatment with a neutralizing antibody against CXCR2 (anti-CXCR2 Ab) (p < 0.05). Finally, anti-CXCR2 Ab significantly reduced tumor volume (p < 0.05), Ki-67 proliferation index (p = 0.043) and Factor VIII+ microvessel density (p = 0.004) in an orthotopic nude mouse PaCa model. Our results show that ELR+-CXC-chemokines promote PaCa tumor-associated angiogenesis through CXCR2, suggesting that CXCR2 is an anti-angiogenic target in PaCa.",
keywords = "Angiogenesis, CXCR2, ELR-CXC-chemokines, Pancreatic cancer",
author = "Yoichi Matsuo and Massimo Raimondo and Woodward, {Timothy A.} and Wallace, {Michael B.} and Gill, {Kanwar R.} and Zhimin Tong and Burdick, {Marie D.} and Zhijian Yang and Strieter, {Robert M.} and Hoffman, {Robert M.} and Sushovan Guha",
year = "2009",
month = "9",
day = "1",
doi = "10.1002/ijc.24383",
language = "English (US)",
volume = "125",
pages = "1027--1037",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

AU - Matsuo, Yoichi

AU - Raimondo, Massimo

AU - Woodward, Timothy A.

AU - Wallace, Michael B.

AU - Gill, Kanwar R.

AU - Tong, Zhimin

AU - Burdick, Marie D.

AU - Yang, Zhijian

AU - Strieter, Robert M.

AU - Hoffman, Robert M.

AU - Guha, Sushovan

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Angiogenesis is essential for tumor growth and metastasis. Although ELR+-CXC-chemokines and their corresponding receptor, CXC-receptor 2 (CXCR2), are known mediators of angiogenesis, little is known about their role in pancreatic cancer (PaCa). The aim of our study was to determine the role of ELR+-CXCchemokine/ CXCR2 biological axis in promoting PaCa angiogenesis. We prospectively collected secretin-stimulated exocrine pancreatic secretions (SSEPS) from normal individuals (NP) and PaCa patients. We showed that summed concentrations of ELR+-CXC-chemokines in SSEPS from PaCa patients were significantly higher than in those from NP (p = 0.002). We measured ELR+-CXC-chemokine levels in supernatants from multiple PaCa cell lines and confirmed that BxPC-3, Colo-357 and Panc-28 had significantly higher expression compared with an immortalized human pancreatic ductal epithelial (HPDE) cell line. After confirming lack of autocrine effects of ELR1-CXC-chemokines on PaCa cells (due to absence of CXCR2 expression), we investigated paracrine effects of these chemokines on human umbilical vein endothelial cells (HUVEC). Both recombinant ELR+-CXC-chemokines and co-culturing with BxPC-3 significantly enhanced proliferation, invasion, and tube formation of HUVEC (p < 0.05). These biological effects were significantly inhibited by treatment with a neutralizing antibody against CXCR2 (anti-CXCR2 Ab) (p < 0.05). Finally, anti-CXCR2 Ab significantly reduced tumor volume (p < 0.05), Ki-67 proliferation index (p = 0.043) and Factor VIII+ microvessel density (p = 0.004) in an orthotopic nude mouse PaCa model. Our results show that ELR+-CXC-chemokines promote PaCa tumor-associated angiogenesis through CXCR2, suggesting that CXCR2 is an anti-angiogenic target in PaCa.

AB - Angiogenesis is essential for tumor growth and metastasis. Although ELR+-CXC-chemokines and their corresponding receptor, CXC-receptor 2 (CXCR2), are known mediators of angiogenesis, little is known about their role in pancreatic cancer (PaCa). The aim of our study was to determine the role of ELR+-CXCchemokine/ CXCR2 biological axis in promoting PaCa angiogenesis. We prospectively collected secretin-stimulated exocrine pancreatic secretions (SSEPS) from normal individuals (NP) and PaCa patients. We showed that summed concentrations of ELR+-CXC-chemokines in SSEPS from PaCa patients were significantly higher than in those from NP (p = 0.002). We measured ELR+-CXC-chemokine levels in supernatants from multiple PaCa cell lines and confirmed that BxPC-3, Colo-357 and Panc-28 had significantly higher expression compared with an immortalized human pancreatic ductal epithelial (HPDE) cell line. After confirming lack of autocrine effects of ELR1-CXC-chemokines on PaCa cells (due to absence of CXCR2 expression), we investigated paracrine effects of these chemokines on human umbilical vein endothelial cells (HUVEC). Both recombinant ELR+-CXC-chemokines and co-culturing with BxPC-3 significantly enhanced proliferation, invasion, and tube formation of HUVEC (p < 0.05). These biological effects were significantly inhibited by treatment with a neutralizing antibody against CXCR2 (anti-CXCR2 Ab) (p < 0.05). Finally, anti-CXCR2 Ab significantly reduced tumor volume (p < 0.05), Ki-67 proliferation index (p = 0.043) and Factor VIII+ microvessel density (p = 0.004) in an orthotopic nude mouse PaCa model. Our results show that ELR+-CXC-chemokines promote PaCa tumor-associated angiogenesis through CXCR2, suggesting that CXCR2 is an anti-angiogenic target in PaCa.

KW - Angiogenesis

KW - CXCR2

KW - ELR-CXC-chemokines

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=67650034624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650034624&partnerID=8YFLogxK

U2 - 10.1002/ijc.24383

DO - 10.1002/ijc.24383

M3 - Article

C2 - 19431209

AN - SCOPUS:67650034624

VL - 125

SP - 1027

EP - 1037

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -